NRL News

News release from Department of Health and Human Services

by | Sep 25, 2018

September 24, 2018

“After a recent review of a contract between Advanced Bioscience Resources, Inc. and the Food and Drug Administration to provide human fetal tissue to develop testing protocols, HHS was not sufficiently assured that the contract included the appropriate protections applicable to fetal tissue research or met all other procurement requirements. As a result, that contract has been terminated, and HHS is now conducting an audit of all acquisitions involving human fetal tissue to ensure conformity with procurement and human fetal tissue research laws and regulations. In addition, HHS has initiated a comprehensive review of all research involving fetal tissue to ensure consistency with statutes and regulations governing such research, and to ensure the adequacy of procedures and oversight of this research in light of the serious regulatory, moral, and ethical considerations involved. Finally, HHS is continuing to review whether adequate alternatives exist to the use of human fetal tissue in HHS funded research and will ensure that efforts to develop such alternatives are funded and accelerated.”


In response, Carol Tobias, NRLC President, commended the action and stated, “HHS has taken a significant step forward in seeking to limit the use of tissue from aborted babies to the extent permitted by law. An internal audit to make sure any and all possible limitations are being followed, as well as looking for alternatives, is a good start.

Categories: Human Embryos